GlaxoSmithKline | GSK - Ebitda





Ebitda Zmiana Data
AbbVie USD 3.52B 828M 2025-09
Alcon AG USD 317M 337M 2025-12
Almirall EUR 114.07M 60.37M 2025-12
Amgen USD 5.14B 775M 2025-12
argenx SE USD 387.05M 99.02M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
Bayer EUR 1.97B 457M 2025-12
Biogen USD 573.2M 253.7M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Fresenius EUR 850M 22M 2025-09
Fresenius Medical Care EUR 1.07B 142.74M 2025-12
Galapagos EUR 2.42M 161.13M 2025-09
Genmab DKK 186M 291M 2025-12
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Glaxosmithkline GBP 4.75B 1.52B 2025-09
GRIFOLS EUR 347.24M 58.35M 2025-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.44B 263M 2025-12
Merck USD 8.39B 1.97B 2025-09
Novartis USD 4.77B 1.11B 2025-12
Novo Nordisk DKK 37.3B 5.86B 2025-12
Orion EUR 343M 207.9M 2025-12
Pfizer USD 6.08B 351M 2025-09
Philips EUR 738M 9M 2025-09
Recordati EUR 247.15M 421K 2025-12
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
Smith & Nephew USD 796M 139M 2025-12
UCB EUR 1.6B 570M 2025-12